Phone: 519-438-9374 Fax: 519-438-8314
February 8, 2021 – The second edition of Nutraceuticals: Efficacy, Safety and Toxicity by Ramesh C. Gupta has been released by Elsevier’s Academic Press, with ...
December 23, 2020 - KGK Science has received an Institutional Cannabis Research License from Health Canada pursuant to the Cannabis Act. In addition to the ...
December 9, 2020 – KGK Science has been contracted by Canadian health supplement company Psyched Wellness to provide a strategic regulatory package of services to ...
November 23, 2020 – KGK Science has been contracted by Fluid Energy Group Ltd. to provide Serious Adverse Reaction Reporting services for their Triton™ Life ...
September 22, 2020 – KGK Science (“KGK”) has received its second Cannabis Research License from Health Canada under the Cannabis Act. This latest license issued ...
September 21, 2020 – A KGK Science clinical trial to investigate the efficacy of a natural health product to ease the symptoms of COVID-19 has launched ...
August 28, 2020 – A recent clinical trial conducted by KGK Science has found evidence to support a natural health product, Relieve-R (formerly Pain Bloc-R), ...
May 26, 2020 – KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth’s CARDIO soft gels, ...
May 19, 2020 – The findings from a clinical trial conducted by KGK Science studying the impact of two single strain probiotics on the severity ...
April 14, 2020 – KGK Science has been recognized by the Global Health & Pharma (GHP) Medical Marijuana Awards as the Best Nutraceutical and Cannabinoid ...
Najla Guthrie, President & CEO of KGK Science, has joined the International Probiotics Association (IPA) Board of Directors, effective April 2020. A global non-profit organization ...
Changing the Tone of Clinical Study Design in the Cannabis Industry The latest cannabis research from KGK Science has been published in the premier research ...
As the status of the COVID-19 pandemic continues to evolve, KGK Science remains committed to the health and safety of our clinical trial participants and ...
KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device KGK Science has been contracted by the Hamilton, Ontario-based neurotech firm, Zentrela Inc. ...
KGK Science announced the appointment of its President and CEO, Najla Guthrie, to the Board of Directors for Natural Products Canada (NPC). As a leader ...
LONDON, ON (October 29, 2019) – A significant shift has taken place in scientific and statistical concepts in the nutraceutical space – a shift that ...
LONDON, ON (October 2019) – KGK Science Inc. (“KGK”) is a different company than it was in 2018. Following their acquisition by Auxly Cannabis Group Inc. ...
LONDON, ON (September 10, 2019) – KGK Science Inc. (“KGK”), a subsidiary of Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly”), has been issued ...
KGK SCIENCE APPLAUDS THE EFFORTS OF CONGRESS TO BEGIN REMOVING REGULATORY HURDLES FOR CBD KGK Science, the leader in providing human clinical trials and regulatory ...
“The Time is Right for Us to Be a Leader at the Table in Those Board Discussions” London, ON – As part of the growth ...
KGK SCIENCE INC. ANNOUNCES APPOINTMENTS OF STEPHEN HOLMES TO CFO &COO AND ASHLEY TEN HAAF TO DIRECTOR OF CLINICAL OPERATIONS London, Ontario, September 10, 2018 ...
KGK SCIENCE INC. ANNOUNCES APPOINTMENT OF MAL EVANS PH.D TO CHIEF SCIENTIFIC OFFICER London, Ontario, August 21, 2018 – Najla Guthrie, President & CEO, of KGK Science ...
IRVINE, Calif., July 20, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for ...
LONDON, ON, NOVEMBER 14, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, will be participating ...
SALINAS, Calif., June 4, 2013—Next Pharmaceuticals acquired the distribution rights, patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize.
LONDON, ON, FEBRUARY 1, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, is very pleased ...
LONDON, ON, January 27, 2012– KGK Synergize Inc. (“KGK”), a product development and contract research organization for the health nutrition industry, announced today the settlement ...
LONDON, ON, JUNE 28, 2011 –Recently, Dr. Mal Evans has been selected as the recipient of the 2010-2011 WIL Award which recognizes individuals and /or ...
Read the article New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid using the link below: https://www.suna.org/download/members/unjarticles/2009/09apr/95.pdf
We're sorry, no results were found.